Headlines & Special Reports

Short the Market using ProShares UltraShort Dow30 (ETF) (NYSEARCA:DXD)

We are currently double short the DJIA using (DXD).  Here is why...

Read More

Gilead Sciences, Inc. (Nasdaq: GILD) Could be on Sale

Is there anything to say about Gilead Sciences, Inc. (Nasdaq: GILD) that hasn’t be said in the past week and a half? The company has been in the news almost daily as itsstockplunged from near $110 on December 19 to $87 just four days later and climbed back to more than $97 yesterday.

Read More

December's action and iPath S&P GSCI Crude Oil Total Return (NYSEARCA:OIL)

Past December's cannot be used to absolutely define the current market we are in today, but they held, so as a result the strategies that I am offering to clients are proactive, they involve high degrees of cost basis improvement and we implement cost basis improvement techniques in the accounts I manage too, but the accurate full disclosure is that my underlying bias is to expect the market to rally from these lows through the end of the year.

Read More

Is Express Scripts Holding Co. (NASDAQ:ESRX) still a Buy?

Berkshire Hathaway Inc.’s (NYSE: BRK.B) only new third-quarter position was Express Scripts Holding Co. (NASDAQ:ESRX), but investors shouldn’t take this as a sign that the largest pharmacy benefit management (or PBM) is right for their portfolios. Express faces a number of challenges in the upcoming year and we may have got a hint of those when the company reported third-quarter sales.

Read More

Valuation analysis for ADTRAN, Inc. (NASDAQ:ADTN)

When earnings collapse the period that lies ahead is one of unusually easy comps, but that wears off fast, and if EPS growth does not continue multiple contractions can come.

Read More